NeuroCure Clinical Research Center   Report issue

For profit Phase 2 Phase 3
Founded: Berlin Germany (2007)

Organization Overview

First Clinical Trial
2011
NCT01440062
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

fingolimod (gilenya) (1 trial)

interferon beta-1b (betaseron) (1 trial)

Drugs in Phase 2 Trials (1)

vitamin d3 (1 trial)

Drugs in Other Trials (2)

cycloserine (seromycin) (1 trial)

fludrocortisone (florinef) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 3)

Neuritis (Phase 3)

Optic Neuritis (Phase 3)

Sclerosis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5